THERAPEUTIKA

European patent · EP2144905 · Deleted

Register entry

Publication number
EP2144905
Application number
EP08742520
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 3, 2008
Published
Jan 20, 2010
Granted
Nov 28, 2012
Deleted
Apr 30, 2018
Reason
Annual fee unpaid
IPC classes
C07D 417/12 (2006.01)
A61K 31/428 (2006.01)
A61P 25/18 (2006.01)
A61P 25/22 (2006.01)
A61P 25/28 (2006.01)
Priority
US 921759 P 04.04.2007
PCT application
PCT/US2008/004336 03.04.2008
PCT publication
WO2008/124030 16.10.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 21, 2018

    Deleted, fee unpaid

    Published in Swissreg on 21.11.2018

  2. Jun 8, 2017

    Transferred

    Owner
    Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA → Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 08.06.2017

  3. Jan 22, 2013

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 22.01.2013

  4. Nov 28, 2012

    Granted

    Published in Swissreg on 28.11.2012

Parties

Inventor

BILODEAU, Mark, T.

Rahway, New Jersey 07065-0907, US

NANDA, Kausik, K.

Rahway, New Jersey 07065-0907, US

TROTTER, B. Wesley

Rahway, New Jersey 07065-0907, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.